Concepedia

Publication | Open Access

Humoral response to a third injection of BNT162b2 vaccine in patients on maintenance haemodialysis

60

Citations

19

References

2021

Year

Abstract

In maintenance HD patients, humoral response against SARS-CoV-2 was boosted after a third dose of BNT162b2, allowing seroconversion in more than half of non-responders. These data may support an intensified vaccination protocol with a third dose of BNT162b2 in dialysis patients.

References

YearCitations

Page 1